About Immunoprofile
Immunoprofile is a private company based in Marco Island, Florida. It has reported $3,180,000 raised in six offerings on Form D since March 2020.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 13, 2025 | Oct 16, 2025 | $225,000of $1.0M target | 3 | $75,000 | EquityRule 506(b) | Form D ↗ |
| Oct 29, 2024 | Nov 13, 2024 | $150,000of $1.0M target | 2 | $75,000 | DebtRule 506(b) | Form D ↗ |
| Jun 26, 2023 | Jul 6, 2023amended May 2, 2024 | $600,000of $900K target | 3 | $200K | EquityRule 506(b) | Form D/A ↗2 earlier filings |
| Dec 31, 2021 | Sep 9, 2022 | $880,000of $1.5M target | 3 | $293K | EquityRule 506(b) | Form D ↗ |
| Feb 24, 2021 | Mar 5, 2021 | $1,165,000of $1.6M target | 8 | $145K | EquityRule 506(b) | Form D ↗ |
| Mar 10, 2020 | Mar 20, 2020 | $160,000of $1.0M target | 1 | $160K | EquityRule 506(b) | Form D ↗ |
| Total, six offerings | $3,180,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Immunoprofile's Form D filed Oct 16, 2025.
SG
Sudip Ghatak
Executive officer and director
WS
William Shea
Executive officer and director